Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials

BACKGROUND: Monoclonal antibodies (mAbs) are currently among the most investigated targets for potential disease-modifying therapies in Alzheimer’s disease (AD). OBJECTIVE: Our objectives were to identify all registered trials investigating mAbs in MCI due to AD or AD at any stage, retrieve availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacorte, Eleonora, Ancidoni, Antonio, Zaccaria, Valerio, Remoli, Giulia, Tariciotti, Leonardo, Bellomo, Guido, Sciancalepore, Francesco, Corbo, Massimo, Lombardo, Flavia L., Bacigalupo, Ilaria, Canevelli, Marco, Piscopo, Paola, Vanacore, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198746/
https://www.ncbi.nlm.nih.gov/pubmed/35275549
http://dx.doi.org/10.3233/JAD-220046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198746/
https://www.ncbi.nlm.nih.gov/pubmed/35275549
http://dx.doi.org/10.3233/JAD-220046

Ejemplares similares